相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction
Daniela Fraccarollo et al.
CIRCULATION (2008)
Inhibition of interleukin-1 by anakinra improves vascular and left ventricular function in patients with rheumatoid arthritis
Ignatios Ikonomidis et al.
CIRCULATION (2008)
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction
Antonio Abbate et al.
CIRCULATION (2008)
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction
Leo Timmers et al.
CIRCULATION RESEARCH (2008)
Cell therapy for acute myocardial infarction
Kai C. Wollert
CURRENT OPINION IN PHARMACOLOGY (2008)
Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice
Alexander Riad et al.
JOURNAL OF IMMUNOLOGY (2008)
Impact of oxypurinol in patients with symptomatic heart failure
Joshua M. Hare et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart (vol 117, pg 3198, 2007)
Joerg Heineke et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart
Joerg Heineke et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Bordlerzone contractile dysfunction is transiently attenuated and left ventricular structural remodeling is markedly reduced following reperfused myocardial infarction in inducible nitric oxide synthase knockout mice
Wesley D. Gilson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure
Tibor Kempf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Aldosterone receptor antagonism induces reverse remodeling when added to angiotensin receptor blockade in chronic heart failure
Anna K. Y. Chan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure
Valerio Zaca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction - The Reversal of ventricular remodeling with Toprol-XL (REVERT) trial
Wilson S. Colucci et al.
CIRCULATION (2007)
Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure
Ping Zhang et al.
CIRCULATION RESEARCH (2007)
Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling
Lepeng Zeng et al.
CIRCULATION (2007)
Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction
Carola Doerries et al.
CIRCULATION RESEARCH (2007)
Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study
Dominic Kelly et al.
EUROPEAN HEART JOURNAL (2007)
Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome
Kai C. Wollert et al.
CIRCULATION (2007)
Effect of high-dose atorvastatin on hospitalizations for heart failure - Subgroup analysis of the treating to new targets (TNT) study
Kiran K. Khush et al.
CIRCULATION (2007)
Role of oxidative stress in cardiac hypertrophy and remodeling
Eiki Takimoto et al.
HYPERTENSION (2007)
Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure
Henry Krum et al.
JOURNAL OF CARDIAC FAILURE (2007)
Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair
Maria Mirotsou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig
Leo Timmers et al.
CIRCULATION (2007)
cGMP-dependent protein kinase type I inhibits TAB1-p38 mitogen-activated protein kinase apoptosis signaling in cardiac myocytes
Beate Fiedler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients:: La Plata study
Horacio E. Cingolani et al.
JOURNAL OF CARDIAC FAILURE (2006)
Chronic matrix metalloproteinase inhibition following myocardial infarction in mice: Differential effects on short and long-term survival
Francis G. Spinale et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction - Results of the PREMIER (prevention of myocardial infarction early remodeling) trial
Michael P. Hudson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study
BM Scirica et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction:: results of the SENIORS echocardiographic substudy
S Ghio et al.
EUROPEAN HEART JOURNAL (2006)
The transforming growth factor-β superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury
T Kempf et al.
CIRCULATION RESEARCH (2006)
Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure
S Sola et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Chronic heart failure: an overview of conventional treatment versus novel approaches
U Landmesser et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2005)
Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction
N Vasilyev et al.
CIRCULATION (2005)
Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy
CM Yu et al.
CIRCULATION (2005)
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
I Shiojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
SD Solomon et al.
CIRCULATION (2005)
Targeted anticytokine therapy and the failing heart
DL Mann
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Mechanisms and models in heart failure the biomechanical model and beyond
DL Mann et al.
CIRCULATION (2005)
Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction
YS Yoon et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
Targeted anticytokine therapy in patients with chronic heart failure - Results of the Randomized Etanercept Worldwide evALuation (RENEWAL)
DL Mann et al.
CIRCULATION (2004)
Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction
L Bolognese et al.
CIRCULATION (2004)
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure
TB Horwich et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Effects of carvedilol on left ventricular remodeling after acute myocardial infarction -: The CAPRICORN echo substudy
RN Doughty et al.
CIRCULATION (2004)
Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury
SP Jones et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Mortality and morbidity reduction with candesartan in patients with chronic heart failure and left ventricular systolic dysfunction - Results of the CHARM low-left ventricular ejection fraction trials
JB Young et al.
CIRCULATION (2004)
Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction -: A new action for an old drug?
N Engberding et al.
CIRCULATION (2004)
Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase
U Landmesser et al.
CIRCULATION (2004)
Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction
T Shishido et al.
CIRCULATION (2003)
Cyclic GMP-dependent protein kinases and the cardiovascular system
R Feil et al.
CIRCULATION RESEARCH (2003)
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling
WM Yarbrough et al.
CIRCULATION (2003)
Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy
K Node et al.
CIRCULATION (2003)
Left ventricular remodeling and ventricular arrhythmias after myocardial infarction
MS Sutton et al.
CIRCULATION (2003)
Downregulation of cytoskeletal muscle LIM protein by nitric oxide - Impact on cardiac myocyte hypertrophy
J Heineke et al.
CIRCULATION (2003)
Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction
AT Askari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Marked improvement in left ventricular ejection fraction during long-term β-blockade in patients with chronic heart failure:: Clinical correlates and prognostic significance
M Metra et al.
AMERICAN HEART JOURNAL (2003)
Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia
A Kawamoto et al.
CIRCULATION (2003)
Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase
F Brunner et al.
CARDIOVASCULAR RESEARCH (2003)
Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction - An experimental serial cardiac magnetic resonance imaging study
M Nahrendorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Left ventricular remodeling after primary coronary angioplasty - Patterns of left ventricular dilation and long-term prognostic implications
L Bolognese et al.
CIRCULATION (2002)
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study
M Wong et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes
B Fiedler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Matrix metalloproteinases - Regulation and dysregulation in the failing heart
FG Spinale
CIRCULATION RESEARCH (2002)
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction
S Hayashidani et al.
CIRCULATION (2002)
Selective matrix metalloproteinase inhibition reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction
ML Lindsey et al.
CIRCULATION (2002)
cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium
JW Wegener et al.
CIRCULATION RESEARCH (2002)
Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death
IN Mungrue et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Gene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes
KC Wollert et al.
HYPERTENSION (2002)
Mechanisms of disease - Aldosterone in congestive heart failure
KT Weber
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice
M Scherrer-Crosbie et al.
CIRCULATION (2001)
Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme A reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction
J Bauersachs et al.
CIRCULATION (2001)
Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines
H Kamihata et al.
CIRCULATION (2001)
Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction
F Sam et al.
CIRCULATION RESEARCH (2001)
Amelioration of angiotensin II-induced cardiac injury by a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
R Dechend et al.
CIRCULATION (2001)
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
B Bozkurt et al.
CIRCULATION (2001)
Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure
BA Groenning et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase
S Kanno et al.
CIRCULATION (2000)
Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling
JN Cohn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
分享论文
